HEPION PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
HEPION PHARMACEUTICALS, INC. (HEPA) had Stock Issued During Period, Shares, New Issues of 8.93 thousand shares as of 2015-10-07, per its 10-K filed 2021-03-31.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2021-03-31
- 2015-10-07: Stock Issued During Period, Shares, New Issues 8.93K shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2015-10-07 | 8.93K shares 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |